Applied Therapeutics, Inc. (APLT) - Net earnings per share (EPS TTM)

Symbol and logo of brand appliedtherapeutics.com (APLT)

Reliable cold chains and diversified suppliers ensure the seamless operation of Applied Therapeutics (APLT) laboratories. Management focuses on the quality of clinical data to successfully bring drugs to market. Business prospects depend on the approval of aldose reductase inhibitors. The current level of annual net income per share illustrates the fundamental earnings, and -0.10 captures the magnitude of this parameter.

APLT (Applied Therapeutics Inc.) Earnings per share for the last 12 months history from 07/04/2022 to 02/16/2026

Comprehensive metric breakdowns and analytics for appliedtherapeutics.com (APLT)

- share price and expert price forecast:
Stock Quotes Applied Therapeutics|APLT - Forecast Levels Chart
- market capitalization indicators:
Market Capitalization Applied Therapeutics, Inc.|APLT - Total Enterprise Value
- business book valuation details:
Book Value per Share Applied Therapeutics|APLT - Accounting Capitalization|Market Cap to Net Assets Ratio appliedtherapeutics.com|APLT - Aggregate Asset Value
- debt and liquidity details:
Debt to Equity Applied Therapeutics|APLT - Long-Term Liabilities to Equity|Short-Term Debt to Capital Applied Therapeutics, Inc.|APLT - Aggregate Debt Obligations|Debts to Book Capitalization Applied Therapeutics, Inc.|APLT - Company Long-Term Debts|Company Short-Term Debt Applied Therapeutics|Quick Liquidity appliedtherapeutics.com
- net income and valuation multiples indicators:
APLT - Net Income|Projected Future Earnings Applied Therapeutics|APLT - P/E Multiple|Forward P/E Multiple Applied Therapeutics|APLT - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Applied Therapeutics, Inc.|APLT - Profit before deduction of interest, taxes, depreciation and amortization|Earnings per share for the last twelve months Applied Therapeutics|APLT - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months appliedtherapeutics.com|APLT - Earnings per share growth in current year|Earnings growth forecast for next year Applied Therapeutics
General company analysis:Applied Therapeutics (APLT)
Mass-produced product of appliedtherapeutics.com

An analysis of the 12-month earnings per share history highlights the specific nature of Applied Therapeutics (APLT) as a developer of orphan drugs. This metric reflects the actual cash return of the business per security, excluding one-time accounting distortions. It measures capitalization efficiency by dividing total net income by the total number of shares. For the biopharmaceutical sector, this indicator serves as a marker of financial stability while awaiting FDA approval. The stability of this figure confirms the company's ability to maintain its balance sheet without excessive borrowing.

Competitors of Applied Therapeutics (APLT)

VRTX: Net earnings per share for the last 12 months|Earnings per one share for the last 12 months ALNY|INSM: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months United Therapeutics Corp (UTHR)|BMRN (BioMarin Pharma) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BBIO (BridgeBio Corp)|Net earnings per share for the last 12 months BGM (BGM Group Ltd)|COGT (cogentbio.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Xeris Biopharma Holdings XERS|KROS (Keros Therapeutics Inc) - Earnings per one share for the last 12 months|Arcturus Pharma - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ETON (Eton Corp)|KMDA: Net earnings per share (EPS TTM)|fulcrumtx.com (FULC) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months Abeona Therapeutics, Inc.|MREO: Earnings per share for the trailing year|Earnings per share for the last twelve months Protalix (PLX)|Net earnings per share for the last 12 months pliantrx.com PLRX|Net earnings per share (EPS TTM) RNTX (Rein Therapeutics Inc)|Net earnings per share (EPS TTM) Gelteq Ltd GELS|Aytu Therapeutics - Net earnings per share (EPS TTM)|CMMB - Net earnings per share (EPS TTM)|srxhealth.com (SRXH) - Earnings per share for the last twelve months|Earnings per one share for the last 12 months PLRZ (Polyrizon)|Earnings per share for the last twelve months Aeterna Zentaris Inc|cyclotherapeutics.com - Earnings per one share for the last 12 months|Earnings per share for the last twelve months Inozyme Pharma, Inc. (INZY)|Earnings per share for the last twelve months RPHM (Reneo Pharmaceuticals Inc.)|Net earnings per share (EPS TTM) CSCI (Aeterna Zentaris)